Synchrony Financial has extended the use of its CareCredit card to Walmart.com, allowing cardholders to purchase eligible health‑and‑wellness items—including medical supplies, fitness equipment, sleep essentials, and pet care—online and at all Walmart and Sam’s Club locations nationwide.
The move deepens a long‑standing partnership with Walmart, which already accepts CareCredit in its stores. Synchrony also powers Walmart’s OnePay credit card program, expected to launch in fall 2025, underscoring a broader strategic alignment between the two companies to embed financing into everyday retail shopping.
By opening Walmart.com to CareCredit, Synchrony is expected to drive higher transaction volume and fee income for its health‑and‑well‑ness credit platform. The expansion taps into Walmart’s vast customer base, potentially increasing the card’s usage beyond traditional healthcare providers and boosting the company’s revenue mix in the consumer‑finance segment.
Synchrony will report its Q1 2026 earnings on April 21, 2026. Analysts project a 24.3% year‑over‑year increase in EPS for the quarter, but the company’s full‑year 2026 EPS guidance of $9.10‑$9.50 fell short of analyst expectations of $9.31, reflecting concerns about a proposed 10% U.S. credit‑card interest‑rate cap and rising costs.
Earlier in April, several analysts adjusted their price targets for Synchrony, lowering them from $93.00 to $82.00 (Barclays) and from $88 to $80 (Evercore ISI). While these revisions were not directly tied to the Walmart expansion, they indicate a cautious outlook amid broader market and regulatory headwinds.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.